Galectin Therapeutics(GALT) - 2025 FY - Earnings Call Transcript

Galectin Therapeutics (NasdaqCM:GALT) FY 2025 Annual General Meeting December 03, 2025 11:00 AM ET Company ParticipantsKhurram Jamil - CMOKevin D. Freeman - Vice ChairmanJoel Lewis - President and CEOJack W. Callicutt - CFONone - Inspector of ElectionsKevin D. FreemanGood morning, ladies and gentlemen. Welcome. My name is Kevin Freeman, and I'm the Vice Chairman of the Board of Galectin Therapeutics, Inc. I will act as Chair of this meeting, and Mr. Jack Callicutt, our Chief Financial Officer and Corporate ...